ClinicalTrials.Veeva

Menu

The Effect of Non-invasive Hemoglobin Measurement in Hip Surgeries

B

Bulent Ecevit University

Status

Completed

Conditions

Hemorrhage
Hemodynamic Instability
Bleeding

Treatments

Device: non-invasive hemoglobin (SpHb)

Study type

Observational

Funder types

Other

Identifiers

NCT04785274
2020-24/16/12/2020

Details and patient eligibility

About

Bleeding is one of the most important causes of mortality and morbidity in patients.

Hb levels are the most prevalently utilized monitoring parameter in hemorrhagic patients in the hemodynamic sense. Hemoglobin determination is studied at laboratories along with blood gasses or complete blood analysis. Recently, non-invasive techniques where measurement is made from the fingertips have been offered for use. One of these techniques is non-invasive hemoglobin (SpHb) measurement. SpHb is used as a trend monitor. Based on the severity of bleeding, the compensatory mechanisms of patients may be disrupted. This situation may lead to lower levels of toleration of anemia during bleeding. The relationship between blood transfusion and mortality is under debate.

Enrollment

40 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18-60 years old
  • General anesthesia undergoing hip surgery
  • American society of anesthesiology (ASA) scores I-II-III

Exclusion criteria

  • Receiving inotropic support
  • Uncontrolled diabetes
  • Arrhythmia
  • Hypothermia
  • Hyperbilirubinemia
  • Jaundice
  • Dark skin pigmentation
  • Without voluntary consent
  • Hypovolemia,
  • hypotension,
  • sepsis,
  • blood diseases

Trial design

40 participants in 2 patient groups

SpHb
Treatment:
Device: non-invasive hemoglobin (SpHb)
Control
Treatment:
Device: non-invasive hemoglobin (SpHb)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems